SE7508565L - Preparat for behandling av infektionssjukdomar forfarande for dess framstellning samt anvendning av dylikt preparat. - Google Patents

Preparat for behandling av infektionssjukdomar forfarande for dess framstellning samt anvendning av dylikt preparat.

Info

Publication number
SE7508565L
SE7508565L SE7508565A SE7508565A SE7508565L SE 7508565 L SE7508565 L SE 7508565L SE 7508565 A SE7508565 A SE 7508565A SE 7508565 A SE7508565 A SE 7508565A SE 7508565 L SE7508565 L SE 7508565L
Authority
SE
Sweden
Prior art keywords
preparation
substant
procedure
treatment
infectious diseases
Prior art date
Application number
SE7508565A
Other languages
English (en)
Swedish (sv)
Inventor
Helmut Stickl
Original Assignee
Helmut Stickl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742437166 external-priority patent/DE2437166C3/de
Application filed by Helmut Stickl filed Critical Helmut Stickl
Publication of SE7508565L publication Critical patent/SE7508565L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
SE7508565A 1974-08-01 1975-07-28 Preparat for behandling av infektionssjukdomar forfarande for dess framstellning samt anvendning av dylikt preparat. SE7508565L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742437166 DE2437166C3 (de) 1974-08-01 Arzneimittel gegen interferonsensible, viralbedingte Infektionskrankheiten

Publications (1)

Publication Number Publication Date
SE7508565L true SE7508565L (sv) 1976-02-02

Family

ID=5922207

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7508565A SE7508565L (sv) 1974-08-01 1975-07-28 Preparat for behandling av infektionssjukdomar forfarande for dess framstellning samt anvendning av dylikt preparat.

Country Status (13)

Country Link
US (1) US4053582A (cs)
JP (1) JPS5141420A (cs)
AT (1) AT343797B (cs)
BE (1) BE831691A (cs)
CA (1) CA1057195A (cs)
CH (1) CH614627A5 (cs)
DK (1) DK141835C (cs)
ES (1) ES439966A1 (cs)
FR (1) FR2280390A1 (cs)
GB (1) GB1517540A (cs)
NL (1) NL7509136A (cs)
SE (1) SE7508565L (cs)
ZA (1) ZA754725B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus
US4309416A (en) * 1979-09-20 1982-01-05 Research Corporation Vaccines from taxonomically similar organisms
EP0037441B1 (en) * 1980-03-10 1984-05-09 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and anti-tumor agent, process for production thereof and microorganism used therein
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
DE3278234D1 (en) * 1981-10-13 1988-04-21 Exovir Inc Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
EP0080032A3 (en) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmaceutical preparation for treating herpetic lesions
US4497795A (en) * 1982-12-13 1985-02-05 The Texas A&M University System Method of regulating appetite and efficiency of food utilization employing interferon
US4820515A (en) * 1982-12-13 1989-04-11 Texas A&M University System Method of using interferon in low dosage to regulate appetite and efficiency of food utilization
US5910304A (en) * 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection
US4820514A (en) * 1985-12-30 1989-04-11 Texas A&M University System Low dosage of interferon to enhance vaccine efficiency
CA1320905C (en) * 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
US4758426A (en) * 1987-06-11 1988-07-19 Ramsdell Bruce V Therapeutic toilet solution and method of dispersion
US5017371A (en) * 1988-01-06 1991-05-21 Amarillo Cell Culture Company, Incorporated Method for reducing side effects of cancer therapy
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
US5124148A (en) * 1988-04-27 1992-06-23 United Cancer Research Institute Method for treating viral diseases with attenuated virus
US5215745A (en) * 1988-04-27 1993-06-01 United Cancer Research Institute Method for treating viral diseases with attenuated virus
DK0696326T5 (da) 1993-04-30 2003-07-14 Wellstat Biologics Corp Anvendelse af NDV til fremstilling af et medikament til behandling af cancer
FR2707458B1 (fr) * 1993-07-12 1995-10-06 Sagal Ingrédients alimentaires obtenus par fermentation avec S. Boulardii et aliments les contenant.
US6140107A (en) * 1996-09-25 2000-10-31 Viva America Marketing, Inc. Organometallic-metabolizing yeast
US20030138454A1 (en) * 1997-06-09 2003-07-24 Oxxon Pharmaccines, Ltd. Vaccination method
GB9711957D0 (en) * 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
GB0118532D0 (en) * 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
GB2382578A (en) * 2001-11-30 2003-06-04 Isis Innovation Fowlpox-based vaccine
CA2467486A1 (en) * 2001-11-30 2003-06-12 Isis Innovation Limited Vaccine
US20050175627A1 (en) * 2003-09-24 2005-08-11 Oxxon Therapeutics Ltd. HIV pharmaccines
DE10349115A1 (de) * 2003-10-22 2005-06-16 Biosyn Arzneimittel Gmbh Kombinationspräparat zur Behandlung der Sepsis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429965A (en) * 1966-08-01 1969-02-25 Sterling Drug Inc Avian pox virus vaccine and process of preparing same

Also Published As

Publication number Publication date
US4053582A (en) 1977-10-11
CH614627A5 (cs) 1979-12-14
JPS5141420A (cs) 1976-04-07
FR2280390B1 (cs) 1980-04-11
ATA598975A (de) 1977-10-15
BE831691A (fr) 1975-11-17
DE2437166A1 (de) 1976-02-19
DE2437166B2 (de) 1977-01-27
GB1517540A (en) 1978-07-12
ZA754725B (en) 1976-06-30
CA1057195A (en) 1979-06-26
DK141835B (da) 1980-06-30
FR2280390A1 (fr) 1976-02-27
AT343797B (de) 1978-06-12
NL7509136A (nl) 1976-02-03
DK141835C (da) 1980-11-10
ES439966A1 (es) 1977-03-01
DK347775A (da) 1976-02-02

Similar Documents

Publication Publication Date Title
SE7508565L (sv) Preparat for behandling av infektionssjukdomar forfarande for dess framstellning samt anvendning av dylikt preparat.
GB1531762A (en) Cancer antigen cancer therapy and cancer diagnosis
EP0046909A3 (en) Pharmaceutical composition
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
GB1501724A (en) Highly attenuated cytomegalovirus vaccine and production thereof
NO790039L (no) 3-azolyl-benzotriazin og -benzotriazin-1-oksyd, fremgangsmaate til deres fremstilling samt deres anvendelse til bekjempelse av plantesykdommer
TR18425A (tr) Amido karboniltiobarbitrueik asit tuerevleri ve bunlarin tuzlari bunlarin hazirlanmasina mahsus usul ve bunlarin insektisid akarisid ve fungisid olarak kullanilmalari
ATE78824T1 (de) Verwendung von nukleosiden zur herstellung eines medikamentes zur behandlung von krankheiten, die durch einen retrovirus oder den hepatitis-b-virus verursacht werden.
SE415035B (sv) Framstellning av urokinas ur en kultur av levande njurceller odlade i nervaro av glycin
BE830577A (fr) Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
EG11811A (en) Process for preparing of anthelmintically active 2-carbalkoxyamino benzimidazolyl-5(6)sulfonic acid phenyl esters and their use for combatting diseases coused by parasites in human and animals
GB1466633A (en) Method for immunizing nursing piglets against transmissible gastroenteritis -tge- virus
ATE3058T1 (de) Herpes-virus-impfstoff und seine herstellung.
AT336190B (de) Verfahren zur herstellung von mikropellets zur behandlung von erkrankungen des mund- und rachenraumes
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
NO165834C (no) Fremgangsmaate for fremstilling av 2,3,4,5-tetrafluor-benzoyl-acetater.
GB1191089A (en) Improvements in or relating to the preparation of beta-Ionone
JPS52125637A (en) Permanent wave liquor
NL180415B (nl) Esters van 2,2-dimethylcyclopropaancarbonzuur, alsmede insecticidepreparaat.
BR7104765D0 (pt) Processo de preparacao de copolimeros de acetato de vinila de ester maleico e de acido crotonico
AR206343A1 (es) Nuevos pigmentos disazoicos derivados de la copulacion de acido antranilico y bis-(2'-hidroxi-3'-naftoil)-4-cloro-1,3-diaminobenceno
IL49374A0 (en) Novel esters of s-triazolobenzopyrazinemethyl thiolphosphoric and thiolphosphonic acids and their thionothiol analogues,their preparation and their use as insecticides
Ch'ing et al. STUDIES ON THE CONTROL OF FECAL-BORNE DISEASES IN NORTH CHINA: XXX. Comparative Studies on the House Frequenting Fly Population of Szechuan, West China: C. NATURAL ENEMIES OF THE COMMON WEST CHINA FLIES
SU523652A1 (ru) Культиватор дл ухода за лесными культурами
HU172062B (hu) Sposob poluchenija slozhnykh efirov alkanolov s korotkojj karbonovojj cep'ju i pirimido-skobka-4,5-b-skobka zakryta-kimolih-4-skobka-3h-skobka zakryta-on-2-karbonovykh kislot

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7508565-4